Skip to content
Wednesday, 18 November 2026
BREAKING
HEALTH

India Develops First Indigenous Bird Flu Vaccine in Bhopal

Bhopals ICAR has developed Indias first indigenous vaccine against bird flu, set to be launched on November 20 by Shivraj Singh Chouhan.

Bhopal, November 18 (Daily Kiran) : The ICAR-National Institute of High Security Animal Diseases in Bhopal has made a significant breakthrough by developing India’s first indigenous vaccine against bird flu, or avian influenza. This vaccine is seen as a major step forward in controlling and preventing the disease within the country’s poultry sector.

On November 20, Union Minister for Agriculture and Farmers Welfare, Shivraj Singh Chouhan, will officially dedicate the inactivated H5N1 highly pathogenic avian influenza (HPAI) virus vaccine to the nation during a ceremony at the institute.

Bird flu poses a serious threat to chickens and other birds, with outbreaks leading to mortality rates as high as 100% among infected flocks. The disease often necessitates the culling of large numbers of birds and can trigger trade restrictions, impacting global markets and causing fluctuations in poultry product prices, which ultimately affect farmers’ livelihoods.

India first reported bird flu in 2006, and since then, over 500 outbreaks of the H5N1 and H5N8 subtypes have been documented. If not effectively controlled, estimates suggest that a major outbreak could reduce India’s GDP growth rate by up to 1.5%, threatening more than 20% of the country’s poultry population.

The 2006 outbreak alone caused an estimated economic loss of between ₹2,200 crore to ₹3,000 crore, while another outbreak in Manipur resulted in economic damage equivalent to 0.5% of the state’s GDP.

Public health concerns also arise from the H5N1 virus. According to the World Health Organization (WHO), there have been 1,003 human cases of H5N1 avian influenza in 25 countries since 2003, resulting in 479 fatalities.

Virological studies indicate that the H5N1 clade 2.3.2.1A strain has been responsible for most outbreaks in chickens. Recently, infections have also been detected in mammals, with three human cases reported.

Until now, there has been no specific commercial vaccine available to protect poultry from the prevalent clade 2.3.2.1A strain. The indigenous vaccine developed in Bhopal aims to address this gap, reducing economic losses for poultry farmers and preventing the virus from spreading to other animals and humans through chickens.

Share